Menta Capital’s Vivani Medical VANI Stock Holding History

Menta Capital’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-538	Closed	-$76K	–	1017
2015 Q4	$76K	Buy	+538	New	+$78.8K	0.01%	838

Other funds holding VANI

HCS

Harvest Capital Strategies San Francisco, California $73.7M AUM 7.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Menta Capital's VANI Position: Q1 2016 in Review

Menta Capital sold out of Vivani Medical (VANI) in Q1 2016, closing a stake of 538 shares — an estimated $76K sold.

Menta Capital first reported a position in VANI in Q4 2015 and held it in 1 quarter. The position peaked at $76K in Q4 2015. 57 funds tracked by Wall St. Rank hold VANI as of Q1 2016.

Menta Capital reported no remaining Vivani Medical position as of Q1 2016 after selling out during the quarter.
Menta Capital sold 538 Vivani Medical shares in Q1 2016, an estimated $76K.
Menta Capital first reported a position in Vivani Medical in Q4 2015 and held it in 1 quarter.
Menta Capital's Vivani Medical position peaked at $76K in Q4 2015.
57 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2016.

Based on Menta Capital's 13F filing for Q1 2016, filed 11 May 2016.